Ricky Goldwasser
Stock Analyst at Morgan Stanley
(3.31)
# 1,057
Out of 5,115 analysts
230
Total ratings
62.89%
Success rate
9.26%
Average return
Main Sectors:
Stocks Rated by Ricky Goldwasser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DOCS Doximity | Upgrades: Overweight | $62 → $65 | $43.78 | +48.47% | 11 | Dec 15, 2025 | |
| CRL Charles River Laboratories International | Maintains: Equal-Weight | $170 → $185 | $203.16 | -8.94% | 23 | Nov 11, 2025 | |
| CNC Centene | Maintains: Equal-Weight | $28 → $38 | $39.89 | -4.74% | 14 | Oct 14, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $325 → $395 | $327.58 | +20.58% | 20 | Sep 12, 2025 | |
| LH Labcorp Holdings | Maintains: Overweight | $283 → $306 | $254.46 | +20.25% | 17 | Jul 25, 2025 | |
| LFST LifeStance Health Group | Reiterates: Overweight | $10 | $7.09 | +41.04% | 8 | Apr 22, 2024 | |
| GDRX GoodRx Holdings | Maintains: Equal-Weight | $8 → $5.5 | $2.77 | +98.56% | 9 | Nov 10, 2023 | |
| OSCR Oscar Health | Maintains: Equal-Weight | $5 → $7.5 | $14.93 | -49.77% | 6 | Aug 30, 2023 | |
| ALHC Alignment Healthcare | Maintains: Overweight | $19 → $12 | $19.15 | -37.34% | 8 | Aug 30, 2023 | |
| DGX Quest Diagnostics | Reiterates: Equal-Weight | $145 | $175.92 | -17.58% | 17 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $365 | $163.47 | +123.28% | 7 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $403 → $420 | $826.43 | -49.18% | 27 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $120 | $4.59 | +2,514.38% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $549 → $620 | $259.25 | +139.15% | 11 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $485 → $500 | $343.30 | +45.65% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $127 → $124 | $79.12 | +56.72% | 9 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $296 → $318 | $274.86 | +15.70% | 11 | Aug 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $74 → $70 | $207.54 | -66.27% | 17 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $182 → $195 | $226.02 | -13.72% | 6 | Oct 21, 2020 |
Doximity
Dec 15, 2025
Upgrades: Overweight
Price Target: $62 → $65
Current: $43.78
Upside: +48.47%
Charles River Laboratories International
Nov 11, 2025
Maintains: Equal-Weight
Price Target: $170 → $185
Current: $203.16
Upside: -8.94%
Centene
Oct 14, 2025
Maintains: Equal-Weight
Price Target: $28 → $38
Current: $39.89
Upside: -4.74%
UnitedHealth Group
Sep 12, 2025
Maintains: Overweight
Price Target: $325 → $395
Current: $327.58
Upside: +20.58%
Labcorp Holdings
Jul 25, 2025
Maintains: Overweight
Price Target: $283 → $306
Current: $254.46
Upside: +20.25%
LifeStance Health Group
Apr 22, 2024
Reiterates: Overweight
Price Target: $10
Current: $7.09
Upside: +41.04%
GoodRx Holdings
Nov 10, 2023
Maintains: Equal-Weight
Price Target: $8 → $5.5
Current: $2.77
Upside: +98.56%
Oscar Health
Aug 30, 2023
Maintains: Equal-Weight
Price Target: $5 → $7.5
Current: $14.93
Upside: -49.77%
Alignment Healthcare
Aug 30, 2023
Maintains: Overweight
Price Target: $19 → $12
Current: $19.15
Upside: -37.34%
Quest Diagnostics
Aug 3, 2023
Reiterates: Equal-Weight
Price Target: $145
Current: $175.92
Upside: -17.58%
Jul 14, 2023
Reiterates: Overweight
Price Target: $365
Current: $163.47
Upside: +123.28%
Jan 6, 2023
Maintains: Overweight
Price Target: $403 → $420
Current: $826.43
Upside: -49.18%
Jan 6, 2023
Maintains: Overweight
Price Target: $140 → $120
Current: $4.59
Upside: +2,514.38%
Oct 31, 2022
Maintains: Overweight
Price Target: $549 → $620
Current: $259.25
Upside: +139.15%
Oct 21, 2022
Maintains: Equal-Weight
Price Target: $485 → $500
Current: $343.30
Upside: +45.65%
Oct 11, 2022
Maintains: Overweight
Price Target: $127 → $124
Current: $79.12
Upside: +56.72%
Aug 17, 2022
Maintains: Overweight
Price Target: $296 → $318
Current: $274.86
Upside: +15.70%
Jul 14, 2022
Maintains: Overweight
Price Target: $74 → $70
Current: $207.54
Upside: -66.27%
Oct 21, 2020
Maintains: Overweight
Price Target: $182 → $195
Current: $226.02
Upside: -13.72%